Articles From: Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing to D+H Integrates Optimal Blue Cloud-Based Solutions with its Mortgage Loan Origination Platform


Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation NEW YORK and SAN DIEGO , Dec.
Sign-up for Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing investment picks
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announces it will be hosting an information session dedicated to its planned STAR pivotal trial and scleroderma, featuring principal investigator Dr.
Sign-up for Cytori to Host an Informational Session on Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna investment picks
Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Thursday, November 6, 2014 at 5:30 PM Eastern Time.
Sign-up for Cytori to Webcast Third Quarter Financial Results on November 6 investment picks
MONMOUTH JUNCTION, N.J. , Jan.
Sign-up for CytoSorbents Announces Closing of Public Offering investment picks
MONMOUTH JUNCTION, N.J. , Dec.
Sign-up for CytoSorbents Submits IDE Application to FDA for U.S. CytoSorb® Cardiac Surgery Trial investment picks
2015/1/7
MONMOUTH JUNCTION, N.J. , Jan.
Sign-up for CytoSorbents To Present at OneMedForum 2015 and Exhibit at the 44th Society of Critical Care Medicine Congress investment picks
Company does not expect estimated timelines to materially change LOS ANGELES , Jan.
Sign-up for CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting Immediate Enrollment of New Patients investment picks
LOS ANGELES , Oct.
Sign-up for CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium investment picks
All Currently Enrolled Patients Can Continue Receiving Aldoxorubicin Therapy or Comparator Drugs; One Inclusion/Exclusion Criteria to be Amended for New Trial Patients to Add Additional Safety Measure Company Expects Trial Timelines to Remain Materially Unchanged LOS ANGELES , Nov.
Sign-up for CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials investment picks
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability 100 Percent of Patients Exhibited Decreased Skin Lesions and a Reduction in Cancer Cells LOS ANGELES , Jan.
Sign-up for CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related Kaposi's Sarcoma (KS) investment picks
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients Novel Albumin-Binding Drug Candidate Appears to Allow Doxorubicin to Cross the Tumor's Blood-Brain Barrier in Humans LOS ANGELES , Jan.
Sign-up for CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer) investment picks
LOS ANGELES , Oct.
Sign-up for CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia investment picks
Company Continues to Expect Clinical Trial Timelines to Remain Materially Unchanged and Expeditiously Resolved LOS ANGELES , Dec.
Sign-up for CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical Trials investment picks
LOS ANGELES , Nov.
Sign-up for CytRx Reports 2014 Third Quarter Financial Results investment picks
LOS ANGELES , Dec.
Sign-up for CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference investment picks
CyweeMotion joins CEVAnet partner program, optimizes Sensor Fusion Hub™ technology for CEVA-TeakLite-4, the industry's lowest power DSP for always-on, context aware smart devices MOUNTAIN VIEW, Calif.
Sign-up for CyweeMotion Partners with CEVA to Offer Complete Sensor Fusion Solution for Mobile and Wearables investment picks
http://media.marketwire.com/attachments/201310/67151_SGI_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159701&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for Czech Republic National Supercomputer Center Selects Powerful SGI Supercomputer to Drive Advanced Scientific Research investment picks
2015/1/9
By Leos Rousek PRAGUE--Car maker Skoda Auto AS sold a million cars in a calendar year for the first time in 2014, the Czech unit of Volkswagen AG (VOW.XE) said Friday.
Sign-up for Czech Skoda Auto 2014 Sales Surge to Record 1.04 Million Cars investment picks
New IBM MobileFirst Apps Help Students Better Manage Personal Finances and Access University Services ARMONK, N.Y. and PRAGUE , Nov.
Sign-up for Czech University of Life Sciences Prague and IBM Enrich the Student Experience with Mobile investment picks
2015/1/8
Levi & Korsinsky, LLP is investigating Caesars Entertainment Corporation (“Caesars Entertainment” or the “Company”) (NasdaqGS:CZR) in connection with possible violations of federal securities laws by the Board of Directors of the Company.
Sign-up for CZR SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Caesars Entertainment Corporation investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0975352001&sourceType=1 http://media3.marketwire.com/logos/20120919-D-BOX200.jpg LONGUEUIL, CANADA --
Sign-up for D-BOX Announces the Opening of Two New Theatres in Mainland China investment picks
First HPAV2 MIMO-certified Device Extends Home Networks over Existing Power Lines LAS VEGAS , Jan.
Sign-up for D-Link Selects Broadcom's HomePlug® AV2 Technology for New AV2 2000 High Speed Powerline Adapter investment picks
Grant will expand college and career-focused STEM curriculum WASHINGTON , Nov.
Sign-up for D.C. Public Schools Expands STEM Curriculum through Multi-Million Dollar Investment from Lockheed Martin investment picks
D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced that the Company will make a presentation to the investment community via webcast at the UBS Building and Building Products Annual CEO Conference on Thursday, November 13, 2014 at 11:45 a.m. Eastern time.
Sign-up for D.R. Horton, Inc. to Present at the UBS Building and Building Products Annual CEO Conference investment picks
D.R. Horton, Inc. (NYSE:DHI), America’s Builder, today reported that pre-tax income for its fourth fiscal quarter ended September 30, 2014 increased 24% to $250.8 million, compared to $202.8 million in the same quarter of fiscal 2013.
Sign-up for D.R. Horton, Inc., America’s Builder, Reports Fourth Quarter and Fiscal 2014 Earnings and Declares Quarterly Dividend of $0.0625 Per Share investment picks
D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced today that the Company will release financial results for its first fiscal quarter ended December 31, 2014 on Monday, January 26, 2015 before the market opens.
Sign-up for D.R. Horton, Inc., America’s Builder, to Release 2015 First Quarter Earnings on January 26, 2015 investment picks
2014/11/11
Sign-up for D.R. Horton's profit rises, but falls short of expectations investment picks
2015/1/14
D+H Announces Dividend Reinvestment Plan Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO , Jan.
Sign-up for D+H Announces Dividend Reinvestment Plan investment picks
2014/11/19
LAKE MARY, FL , Nov.
Sign-up for D+H Helps Clients Prepare for Final TILA-RESPA Ruling with Mortgage Reform School investment picks
2014/12/3
Integration Creates More Efficient and Comprehensive Origination Workflow LAKE MARY, FL , Dec.
Sign-up for D+H Integrates Optimal Blue Cloud-Based Solutions with its Mortgage Loan Origination Platform investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing to D+H Integrates Optimal Blue Cloud-Based Solutions with its Mortgage Loan Origination Platform
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent